RENAL AND HEPATIC IMPAIRMENT BROUGHT ON BY CISPLATIN WITHOUT COMPROMISING ANTICANCER EFFICACY. RJDNMD. 2024;31(1):394-406. Accessed May 18, 2024. https://jrdiabet.ro/index.php/RJDNMD/article/view/307